Failure of Phorbol Myristate Acetate to Damage DNA in Leukocytes from Patients with Chronic Granulomatous Disease
- 1 December 1982
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 38 (3) , 1299-1300
- https://doi.org/10.1128/iai.38.3.1299-1300.1982
Abstract
Unlike leukocytes from normal donors, leukocytes from patients with chronic granulomatous disease do not suffer DNA damage on exposure to the tumor promoter, phorbol myristate acetate.This publication has 6 references indexed in Scilit:
- DNA Strand Breakage in Human Leukocytes Exposed to a Tumor Promoter, Phorbol Myristate AcetateScience, 1982
- FLUOROMETRIC METHOD FOR RAPID DETECTION OF DNA STRAND BREAKS IN HUMAN WHITE BLOOD-CELLS PRODUCED BY LOW-DOSES OF RADIATION1981
- Defect in the Oxidative Killing of Micro-organisms by Phagocytic LeukocytesPublished by Wiley ,1979
- NADPH oxidase deficiency in X-linked chronic granulomatous disease.Journal of Clinical Investigation, 1975
- Defective Superoxide Production by Granulocytes from Patients with Chronic Granulomatous DiseaseNew England Journal of Medicine, 1974
- Leukocyte Oxidase: Defective Activity in Chronic Granulomatous DiseaseScience, 1967